Menopur Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

menopur

ferring pharmaceuticals pty ltd - gonadotrophin - menopausal human -

DURATOCIN carbetocin 100 microgram/mL injection vial Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

duratocin carbetocin 100 microgram/ml injection vial

ferring pharmaceuticals pty ltd - carbetocin, quantity: 100 microgram/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; succinic acid; methionine; mannitol - duratocin is indicated for the prevention of uterine atony and excessive bleeding following delivery of the infant by caesarean section or vaginal delivery.,duratocin must be administered after delivery of the infant.

MENOPUR gonadotrophin Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

menopur gonadotrophin

ferring pharmaceuticals pty ltd - human menopausal gonadotrophin, quantity: 1200 iu - injection, solvent for - excipient ingredients: water for injections; metacresol - menopur is indicated for the treatment of infertility in the following clinical situations:,anovulatory infertility, including polycystic ovarian disease (pcod), in women who have been unresponsive to treatment with clomiphene citrate.,controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).

MENOPUR gonadotrophin Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

menopur gonadotrophin

ferring pharmaceuticals pty ltd - human menopausal gonadotrophin, quantity: 600 iu - injection, solvent for - excipient ingredients: water for injections; metacresol - menopur is indicated for the treatment of infertility in the following clinical situations:,anovulatory infertility, including polycystic ovarian disease (pcod), in women who have been unresponsive to treatment with clomiphene citrate.,controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).